Key facts
- Pluro Fertility and IVF’s last known valuation is $69.6M (Oct 2025).
- It has raised $2.9M across 1 recorded rounds; the latest was Early Stage VC (Series A) ($2.9M) in Oct 2025.
- Notable investors include Bessemer Venture Partners, Dharmil Sheth, Hardik Dedhia, Karan Kapur, Niket Shah — 8 tracked in total.
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Pluro Fertility and IVF
Funding rounds
1 roundsAbout Pluro Fertility and IVF
Operator of a fertility and reproductive health care network intended to achieve parenthood through advanced reproductive technologies and personalised care. The company offers services including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), egg and sperm donation, genetic testing (PGT), egg and embryo freezing, surrogacy, hormonal and semen analysis, and fertility preservation, enabling individuals and couples to access transparent and doctor-supervised treatment with around-the-clock support and teleconsultations.
- Industry
- Clinics/Outpatient Services
- Sector
- Healthcare
- HQ
- Mumbai, India
- Founded
- 2025
- Website
- pluro.in/
- Ownership
- Privately Held (backing)
Pluro Fertility and IVF doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Pluro Fertility and IVF shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Pluro Fertility and IVF in its N-PORT filings yet. We sweep new filings monthly.